Recurrences and progression of superficial bladder cancer following long-term intravesical prophylactic therapy with mitomycin C: 48-month follow-up

Urologia Internationalis

Volumn 56, Issue 4, 1996, Pages 234-237

  Minervini, Riccardo ^a   Felipetto, R ^a   Vigano L ^a   Pampaloni, S ^a   Fiorentini, L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Mitomycin C; Prophylaxis; Superficial transitional cell carcinoma

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; MITOMYCIN C;

ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; CYSTOSCOPY; DRUG EFFICACY; FEMALE; HEMATURIA; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; TRANSURETHRAL RESECTION; URINE CYTOLOGY;

EID: 0030000492     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000282849     Document Type: Article

References (19)

1. Shida K, Tatani M, Kato N, Urano E, Oogoshi M, Tazaki H, Ozeki Z, Mitsunaga S, Yajima H. Nakagami Y, Nakamura Y: Treatment of the bladder cancer with instillation of mitomycin C. Jpn J Clin Urol 1967:21:1075-1079.
2. Niijima T, Koisok T, Akaza H: Randomized trial on chemoprophylaxis of recurrences in cases of superficial bladder cancer. Cancer Chemother Pharmacol 1983:11 (suppl):79-83.
3. Zincke H, Balph C, Bensan JR, Hilton JF, Taylor WF: Intravesical Thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: A prospective, randomized, stratified study with crossover design. J Urol 1985:134:1110-1114.
4. Jauhiainen K, Alfthan O: Instillation of mitomycin C and doxorubicin in the prevention of recurrent superficial (Ta-Tl) bladder cancer. Br J Urol 1987;60:54-59.
5. Huland H, Klöppel G, Feddersen I, Otto U, Brachmann W, Hubmann H, Kaufmann J. Knipper W, Lantzius-Beninga F, Huland E: Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: Final evaluation of prospective multicenter study with 419 patients. J Urol 1990:144:68-71.
6. Soloway MS, Perito PE: Superficial bladder cancer: Diagnosis, surveillance and treatment. J Cell Biochem Suppl 1992; 16:120-127.
7. Soloway MS: The evaluation and follow-up of patients with Ta, Tcis, and T1 bladder cancer. World J Urol 1993;11:153-155.
8. Soloway MS: Overview of treatment of superficial bladder cancer. Urology 1985;26(suppl): 18-26.
9. Flüchter SH, Harzmann R, Hlobil H, Erdmann W. Bichler KH: Lokale Chemotherapie des Harnblasenkarzinoms mit Mitomycin. Urologe 1982:21:24-28.
10. Soloway MS: Selecting initial therapy for bladder cancer. Cancer 1987;60(suppl):502-513.
11. Wientjes MG, Badalament RA, Au JLS: Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer. Cancer Chcmother Pharmacol 1993:32:255-262.
12. Hellsten S, Mansson W, Henrikson H, Idwall I, Lindholm K, Mikulowsky P, Martensson S, Oldbring J: Intravesical mitomycin C for the carcinoma in situ of the urinary bladder. Scand U Urol Nephrol 1990:24:35-38.
13. Minervini R, Felipetto R, Viganö L. Cecchi M: Treatment of bladder carcinoma in situ with mitomycin C: Long-term follow-up. Int Urol Neph 1994:26:437-442.
14. Minervini R, Ceechi M, Morelli G, Sepich CA, Benvenuti S, Berutto N: Intracavitary prophylactic treatment of superficial carcinoma of the bladder with mitomycin C: 9 years experience. Eur Urol 1990; 18(suppl):382.
15. Cccchi M, Benvenuti S, Morelli G, Minervini R: La mitomicina C nella prevenzione delle recidive dei tumori superficiali della vescica: 10 anni di esperienza. Acta Urol Ital 1992:4: 137-140.
16. Badalament RA, Herr HW, Wong GY, Gnecco C, Pinsky CM, Whitmore WE, Fair WR, Octt-gen HF: A prospective randomized trial of maintenance versus nonmaintcnance intravesical bacillus Calmclte-Guerin therapy of superficial bladder cancer. J Clin Oncol 1987:5: 441-449.
17. Van der Meijden ADPM, De Bruvne FMJ: Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: Short-term courses or maintenance therapy. Urology 1988:26:31-33.
18. Niall MH: Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin North Am 1992:19: 429-433.
19. Hamdy FC, Bastie KJ, Kerry R, Williams JL: Mitomycin-C in superficial bladder cancer. Is long-term maintenance therapy worthwhile after initial treatment? Br J Urol 1993:71:183-186.